Invest To Save Lives And Make Profits With Low-cost Insulin And Rapid, Accurate, COVID Tests Plus Alternative Investment Opportunities
BiologX Proprietary Technology Rapidly Produces Insulin, Intended to sell at 60% Less Than Current Prices to the Patient
BiologX has developed unique processes for the production of Insulin that enable them to make high-quality insulin in the US at lower cost. Attractive Investment that can save lives.
The BiologX offering has been qualified by the SEC and accepting investments on Manhattan Street Capital.
Anyone can invest — Minimum Investment $320
A highly accurate, portable and reusable COVID self-test for smartphones
Purdue University and IdentifySensors Biologics have partnered to create Check4-COVID™: a highly accurate, over-the-counter device intended to detect COVID-19 RNA in minutes in early and asymptomatic infections.
The device uses newly developed nanosensors, saliva, and a smartphone to pinpoint infections in minutes that current tests and home tests miss. It is intended to be sold at pharmacies at $120 for the device and $21 for each test.
The system will also detect the new variants of COVID-19. This over-the-counter device is intended to be used entirely at home, at work or on the go without a lab or a prescription. You get a text message on your smartphone in minutes.
Anyone can invest — Minimum Investment $323
Invest in companies developing virus tests, treatments, and vaccines and much more
By investing you enable us to invest and lend capital to select companies that are developing virus tests, medicines, vaccines and related technologies that protect the public.
The Manhattan Street Fund will lend and invest to provide capital to enable successful Reg A+ public offerings and IPOs. We will make distributions of profit quarterly and we intend to provide monthly redemptions with reasonable limits.
For accredited investors — Act now to lock in the current Convertible Note conversion cost per Unit of $1.40 — it will increase to $2.00 per Unit at Midnight today Weds March 10th Pacific. We intend that your investment will convert into Units in the Reg A+* at the value of $4.00 (at the pre-money valuation for the Reg A+* of $50 mill). *Subject to SEC Qualification. Conversion is optional.
Building compact and portable test devices to detect COVID-19.
Edoceo is raising $20M with their Reg A+ offering to fast-track development of a testing platform Called V-Detect, their SARS-CoV-2 Virus Test for use in Doctor’s offices, Clinics, and Airports.
- Results in under 30 minutes
- Accurate method that greatly reduces false positive and negative results
- COVID-19 test based on RNA amplification
- Plus New Covid-19 Antigen Test
Anyone can invest — Minimum Investment $580
CalTier realty specializes in multi-family investments across the united states
Multi-Family Real Estate Investment Fund Building a diversified multi-family real estate portfolio.
Multi-Family properties produce steady cash flows while maintaining lower volatility when compared to other real estate types. CalTier is based in San Diego California and pays quarterly distributions.
Anyone can invest — Minimum investment $500
Rod Turner is a seasoned serial entrepreneur. CEO of Manhattan Street Capital, founder and General Partner of the Manhattan Street Fund, he helps CEOs raise capital via IPOs, Regulation A+ for Mid-Stage companies. Manhattan Street Capital, 858 366 2585
Check the Offering Circular or PPM on any offering before investing for important details.
© Copyright 2019 Manhattan Street Capital, Inc. All rights reserved. Patents pending. Copyright and Trademarks owned by Manhattan Street Capital